Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick C Ma

Showing results (51-60 of 85) with videos related to

Pageof 9
Sort By:
The Journal of Molecular Diagnostics : JMD|March 19, 2013
ALK status testing in non-small cell lung carcinoma: correlation between ultrasensitive IHC and FISHEugen C Minca, Bryce P Portier, Zhen Wang, et al.
Clinical Chemistry|November 21, 2015
Quantification of Anaplastic Lymphoma Kinase Protein Expression in Non-Small Cell Lung Cancer Tissues from Patients Treated with CrizotinibTodd Hembrough, Wei-Li Liao, Christopher P Hartley, et al.
Clinical Lung Cancer|October 9, 2024
Use of Oncogene Overlap by Tissue-Based Next-Generation Sequencing to Explore the Mutational Landscape and Survival Impact of HER2, KRAS and MET Copy-Number Gain in Nonsmall Cell Lung CancerAlexander S Watson, Harris B Krause, Andrew Elliott, et al.
Lung Cancer (Amsterdam, Netherlands)|January 14, 2026
SEZ6 expression and lineage plasticity in small cell lung cancer and transformed non-small cell lung cancerJennifer A Marks, Kieran Sweeney, Andrew Elliott, et al.
Cancer Research|April 8, 2025
SCD1 Inhibition Blocks the AKT-NRF2-SLC7A11 Pathway to Induce Lipid Metabolism Remodeling and Ferroptosis Priming in Lung AdenocarcinomaUtsav Sen, Charles Coleman, Nishant Gandhi, et al.
Cancers|May 13, 2026
Transferrin Receptor Overexpression in Solid Tumors Is Associated with Inflamed Microenvironments and Upregulated Immune Checkpoints, with Implications for Immunotherapy SensitivityAsaad Trabolsi, Marianna Lekakis, Peter M Commisso, et al.
Lung Cancer (Amsterdam, Netherlands)|September 6, 2024
Molecular profiling METex14+ non-small cell lung cancer (NSCLC): Impact of histologyJennifer A Marks, Nishant Gandhi, Balazs Halmos, et al.
Oncotarget|June 19, 2017
YB-1 regulates tumor growth by promoting MACC1/c-Met pathway in human lung adenocarcinomaTao Guo, Shilei Zhao, Peng Wang, et al.
Genes, Chromosomes & Cancer|August 19, 2008
Expression and mutational analysis of MET in human solid cancersPatrick C Ma, Maria S Tretiakova, Alexander C MacKinnon, et al.
Journal of Cancer Research and Clinical Oncology|May 29, 2017
AXL-GAS6 expression can predict for adverse prognosis in non-small cell lung cancer with brain metastasesXiaoliang Wu, Wenjuan Ma, Qianghua Zhou, et al.
Pageof 9

Showing results (51-60 of 85) with videos related to

Sort By:
Pageof 9
The Journal of Molecular Diagnostics : JMD|March 19, 2013
ALK status testing in non-small cell lung carcinoma: correlation between ultrasensitive IHC and FISHEugen C Minca, Bryce P Portier, Zhen Wang, et al.
Clinical Chemistry|November 21, 2015
Quantification of Anaplastic Lymphoma Kinase Protein Expression in Non-Small Cell Lung Cancer Tissues from Patients Treated with CrizotinibTodd Hembrough, Wei-Li Liao, Christopher P Hartley, et al.
Clinical Lung Cancer|October 9, 2024
Use of Oncogene Overlap by Tissue-Based Next-Generation Sequencing to Explore the Mutational Landscape and Survival Impact of HER2, KRAS and MET Copy-Number Gain in Nonsmall Cell Lung CancerAlexander S Watson, Harris B Krause, Andrew Elliott, et al.
Lung Cancer (Amsterdam, Netherlands)|January 14, 2026
SEZ6 expression and lineage plasticity in small cell lung cancer and transformed non-small cell lung cancerJennifer A Marks, Kieran Sweeney, Andrew Elliott, et al.
Cancer Research|April 8, 2025
SCD1 Inhibition Blocks the AKT-NRF2-SLC7A11 Pathway to Induce Lipid Metabolism Remodeling and Ferroptosis Priming in Lung AdenocarcinomaUtsav Sen, Charles Coleman, Nishant Gandhi, et al.
Cancers|May 13, 2026
Transferrin Receptor Overexpression in Solid Tumors Is Associated with Inflamed Microenvironments and Upregulated Immune Checkpoints, with Implications for Immunotherapy SensitivityAsaad Trabolsi, Marianna Lekakis, Peter M Commisso, et al.
Lung Cancer (Amsterdam, Netherlands)|September 6, 2024
Molecular profiling METex14+ non-small cell lung cancer (NSCLC): Impact of histologyJennifer A Marks, Nishant Gandhi, Balazs Halmos, et al.
Oncotarget|June 19, 2017
YB-1 regulates tumor growth by promoting MACC1/c-Met pathway in human lung adenocarcinomaTao Guo, Shilei Zhao, Peng Wang, et al.
Genes, Chromosomes & Cancer|August 19, 2008
Expression and mutational analysis of MET in human solid cancersPatrick C Ma, Maria S Tretiakova, Alexander C MacKinnon, et al.
Journal of Cancer Research and Clinical Oncology|May 29, 2017
AXL-GAS6 expression can predict for adverse prognosis in non-small cell lung cancer with brain metastasesXiaoliang Wu, Wenjuan Ma, Qianghua Zhou, et al.
Pageof 9